Recent advances in diagnosis and treatment of primary aldosteronism

Minerva Medica

Volumn 94, Issue 4, 2003, Pages 259-265

  Veglio, F ^a,b   Morello, F ^a   Rabbia, F ^a   Leotta, G ^a   Mulatero, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Ospedale San Vito   (Italy)

Author keywords

Aldosterone; Hyperaldosteronism; Hypertension; Mineralcorticoids; Renin

Indexed keywords

ALDOSTERONE; ALDOSTERONE RECEPTOR; ALDOSTERONE RECEPTOR ANTAGONIST; AMILORIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; CANRENOATE POTASSIUM; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; FLUDROCORTISONE; GLUCOCORTICOID; MINERALOCORTICOID; PROGESTERONE RECEPTOR; RENIN; SODIUM CHLORIDE; SPIRONOLACTONE; TRIAMTERENE; UNCLASSIFIED DRUG; VERAPAMIL;

ADRENAL HYPERPLASIA; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; AMBULATORY MONITORING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DRUG MECHANISM; ERECTILE DYSFUNCTION; ESSENTIAL HYPERTENSION; GLUCOCORTICOID REMEDIABLE ALDOSTERONISM; GYNECOMASTIA; HUMAN; HYPERTENSION; MENSTRUAL IRREGULARITY; MICROADENOMA; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PROVOCATION TEST; REFERENCE VALUE; REVIEW; SCREENING TEST; SIDE EFFECT;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE; BIOLOGICAL MARKERS; GLUCOCORTICOIDS; HUMANS; HYPERALDOSTERONISM; RENIN;

EID: 0242695625     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Conn JW. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955;45:3-17.
2. Ganguly A. Primary aldosteronism. N Engl J Med 1998;339:1828-34.
3. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994;21:315-8.
4. Stowasser M. Primary aldosteronism: rare bird or common cause of secondary hypertension? Curr Hypertens Rep 2001;3:230-9.
5. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997;20:85-90.
6. Halimi JM, Mimran A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995;13:1801-2.
7. Montori VM, Young WF Jr. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 2002;31:619-32,xi.
8. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002;40:897-902.
9. Moneva MH, Gomez-Sanchez CE. Establishing a diagnosis of primary aldosteronism. Curr Opin Endocrinol Diab 2001;8:124-9.
10. Agharazii M, Douville P, Grose JH, Lebel M. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 2001;37:1440-3.
11. Young WF, Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev 1999;7:207-14.
12. Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 2000;85:4526-33.
13. Young WF Jr. Primary aldosteronism. Management Issues. Ann N Y Acad Sci 2002;970:61-76.
14. Magill SB. Adrenal vein sampling: an overview. Endocrinologist 2001;11:357-63.
15. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001;86:1066-71.
16. Lim PO, Young WF, Mac Donald TM. A review of the medical treatment of primary aldosteronism. J Hypertens 2001;19:353-61.
17. Meria P, Kempf BF, Hermieu JF, Plouin PF, Duclos JM. Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. J Urol 2003;169:32-5.
18. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S et al. A chimaeric 11b-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992;355:262-5.
19. Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P et al. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab 1998;83:3996-4001.